Panomni-D vs Omnizole-D: Choosing the Right Capsule

Both are prescription capsules marketed by EMK Omni Pharma in the anti gastric and acidity category, and both are built on the same idea. A proton pump inhibitor lowers the amount of acid the stomach makes, and domperidone supports the movement of the stomach so that meals do not sit and press upward.

Both use a modified-release design. The acid-reducing molecule is protected from stomach acid by a coating, and the domperidone is formulated to release over a period rather than all at once. In both cases the capsule is swallowed whole and never opened, chewed or crushed.

Both carry the Schedule H warning, so a chemist can dispense either only against a valid prescription. Both are marketed by EMK Omni Pharma and produced at contract manufacturing units working to good manufacturing practice standards, with batch number, manufacturing date, expiry date and MRP printed on the pack.

The difference is the proton pump inhibitor and the way each release system is described on the pack.

Panomni-D contains Pantoprazole Sodium IP equivalent to Pantoprazole 40 mg in gastro-resistant form together with Domperidone IP 30 mg in prolonged-release form. Its full generic description is Pantoprazole Gastro-resistant and Domperidone Prolonged-release Capsules IP, and it is supplied as 10 x 10 capsules.

Omnizole-D is an Esomeprazole enteric-coated and Domperidone sustained-release capsule. For its strengths, read the pack label, since these are confirmed on the printed pack rather than assumed.

Esomeprazole is a single isomer refinement within the same drug family. Both molecules block the same pump. Where they part company is in how the liver handles them, which shapes the interaction profile, and in how each behaves in people with liver impairment. Pantoprazole is often described as having a comparatively straightforward interaction profile within the class, which can matter for a patient already taking several medicines.

The prescription is a judgement built from several pieces of information, and symptom severity is only one of them.

Sometimes the right answer is neither combination. If a patient has acid symptoms with no motility complaint, a single molecule product may be more appropriate, and adding domperidone without a reason is not good practice.

Two products can look interchangeable on a shelf and still be different decisions for your body.

Switching without advice can undo a plan that was built around your other medicines. It can also mask what is really happening, because a change in symptoms after a self-made switch tells your doctor very little. If a heart rhythm concern or a liver issue was the reason a particular combination was chosen, changing it quietly removes that safeguard.

The same applies to stopping early, restarting an old strip months later, or accepting a substitute at the counter because your brand is out of stock. Ask the chemist to call your doctor, or take a photograph of the prescription and check before buying anything different.

If cost, availability or the size of the capsule is the real problem, say so at the consultation. Doctors can usually work with that, and an honest conversation gives a better result than a silent substitution.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.

Take a short list with you. It makes a five minute consultation far more useful.

Write down the answers. Bring the pack or a photograph of the strip to every visit, so the exact composition and batch are clear rather than remembered.